LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
about
LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@ast
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@en
type
label
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@ast
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@en
prefLabel
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@ast
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@en
P2093
P2860
P1433
P1476
LPSF/GQ-02 inhibits the develo ...... c fatty liver disease (NAFLD).
@en
P2093
Amanda Costa Oliveira
Amanda Karolina Soares e Silva
Bruna dos Santos Silva
Christina Alves Peixoto
Dilênia de Oliveira Cipriano Torres
Edlene Lima Ribeiro
Fabiana Oliveira dos Santos Gomes
Ivan da Rocha Pitta
Laise Aline Martins dos Santos
Maria do Carmo Alves de Lima
P2860
P304
P356
10.1371/JOURNAL.PONE.0123787
P407
P577
2015-04-14T00:00:00Z